#covaxine in india

[gofitnesspro]

How to keep yourself safer and protected from the new COVID-19 Variant XBB.1.5 of 2023?

New COVID-19 Variant XBB.1.5 What is XBB.1.5? The New COVID-19 variant XBB.1.5 was discovered for the first time in the US in New York in October 2022. It is a recombinant or hybrid virus subvariant, which means it consists of two strains, in this case, two descendants of the Omicron BA.2 sub lineage. The XBB.1.5 variation features a mutation that virologists think makes the virus more capable…

[5gdiginews]

ICMR draws flak from experts over call for BHU study retraction - ET HealthWorld

New Delhi: universal health organization ,ooh), a group of epidemiologists, doctors and public health Expertswritten to Indian Council of Medical Research ,ICMR) asked it to avoid academic censorship, as it was later questioned by researchers. Banaras Hindu University (BHU) was honoured for its latest study on the side effects of India’s indigenous Covid-19 vaccine. vaccine, Covaxin, In their…

[market-news-24]

Today's Current Affairs: AstraZeneca Covid Vaccine Linked To Rare Blood Clotting Disorder If you're keeping up with the latest news, you might have heard about the recent findings regarding the AstraZeneca Covid-19 vaccine. Researchers have discovered a rare but fatal blood clotting disorder known as vaccine-induced immune thrombocytopenia and thrombosis (VITT) linked to the vaccine. The vaccine, developed in collaboration with Oxford University, has been sold as Covishield in India and Vaxzevria in Europe. The discovery of VITT has raised concerns about the safety of the vaccine, with researchers identifying a dangerous blood autoantibody directed against a protein called platelet factor 4 (PF4) as the culprit. This new research has important implications for vaccine safety and development, as well as shedding light on the genetic risk factors associated with the disorder. AstraZeneca has acknowledged the rare side effect and has taken steps to address the issue, including withdrawing the vaccine from certain markets. Stay informed about the latest developments in today's current affairs to stay ahead of the curve. [ad_2] Download Latest Movies in HD Quality Downloading In 15 seconds Scroll Down to End of This Post const downloadBtn = document.getElementById('download-btn'); const timerBtn = document.getElementById('timer-btn'); const downloadLinkBtn = document.getElementById('download-link-btn'); downloadBtn.addEventListener('click', () => downloadBtn.style.display = 'none'; timerBtn.style.display = 'block'; let timeLeft = 15; const timerInterval = setInterval(() => if (timeLeft === 0) clearInterval(timerInterval); timerBtn.style.display = 'none'; downloadLinkBtn.style.display = 'inline-block'; // Add your download functionality here console.log('Download started!'); else timerBtn.textContent = `Downloading In $timeLeft seconds`; timeLeft--; , 1000); ); [ad_1] 1. What is the rare but fatal blood clotting disorder associated with AstraZeneca's Covid-19 vaccine? - A. Vaccine-induced thrombosis and thrombocytopenia - B. Vaccine-related allergic reaction - C. Vaccine-induced fever and fatigue - D. Vaccine-associated muscle pain Answer: A. Vaccine-induced thrombosis and thrombocytopenia 2. What is the name of AstraZeneca's Covid-19 vaccine in India? - A. Covaxin - B. Covishield - C. Comirnaty - D. Moderna Answer: B. Covishield 3. In a research published in the New England Journal of Medicine, what did international experts identify in the PF4 antibodies associated with blood clotting disorders? - A. Different molecular fingerprints - B. Common genetic risk factors - C. New antigen targets - D. Unique vaccine components Answer: B. Common genetic risk factors 4. What rare side effect has been linked to the AstraZeneca Covid vaccine, causing blood clots and low blood platelet count? - A. Thrombocytosis - B. Thrombosis - C. Thrombotic Thrombocytopenic Syndrome (TTS) - D. Thrombophlebitis Answer: C. Thrombotic Thrombocytopenic Syndrome (TTS) [ad_2] What is the AstraZeneca Covid-19 vaccine known as in India? The AstraZeneca's Covid-19 vaccine was named CoviShield in India. What is VITT and how is it related to the AstraZeneca vaccine? VITT stands for vaccine-induced immune thrombocytopenia and thrombosis, which is a rare but fatal blood clotting disorder. It has been found to be related to the adenovirus vector-based Oxford-AstraZeneca vaccine, sold as Covishield in India and Vaxzevria in Europe. What was found to be the reason for VITT in relation to the AstraZeneca vaccine? An unusually dangerous blood autoantibody directed against a protein termed platelet factor 4 (or PF4) was found to be the reason for VITT in relation to the AstraZeneca vaccine. What have researchers discovered in a new study regarding PF4 antibodies? Researchers in a new study have found that the PF4 antibodies in both adenovirus

infection-associated VITT and classic adenoviral vector VITT share identical molecular fingerprints or signatures. They also noted that the pathways of lethal antibody production in these disorders must be virtually identical and have similar genetic risk factors. What important clinical implications have researchers mentioned regarding their findings? Researchers have noted that the findings regarding VITT have important clinical implications for rare cases of blood clotting after adenovirus (a common cold) infections, as well as implications for vaccine development. Lessons learned from VITT can be applicable to these cases and can help improve vaccine safety. [ad_1] Download Movies Now Searching for Latest movies 20 seconds Sorry There is No Latest movies link found due to technical error. Please Try Again Later. function claimAirdrop() document.getElementById('claim-button').style.display = 'none'; document.getElementById('timer-container').style.display = 'block'; let countdownTimer = 20; const countdownInterval = setInterval(function() document.getElementById('countdown').textContent = countdownTimer; countdownTimer--; if (countdownTimer < 0) clearInterval(countdownInterval); document.getElementById('timer-container').style.display = 'none'; document.getElementById('sorry-button').style.display = 'block'; , 1000); [ad_2] Today's current affairs bring to light a concerning discovery regarding the AstraZeneca Covid-19 vaccine. Researchers have found that the vaccine may increase the risk of a rare but fatal blood clotting disorder known as vaccine-induced immune thrombocytopenia and thrombosis (VITT). This disorder, caused by an autoantibody targeting a protein called platelet factor 4 (PF4), has been linked to the adenovirus vector-based AstraZeneca vaccine, sold as Covishield in India and Vaxzevria in Europe. Further research has shown that the PF4 antibodies in VITT after adenovirus infection and in classic adenoviral vector-induced VITT share identical molecular fingerprints. This has led experts to believe that the pathways of lethal antibody production in these disorders are virtually identical. The implications of these findings extend to improving vaccine safety and understanding rare cases of blood clotting after adenovirus infections. These revelations come after AstraZeneca acknowledged in a legal document submitted to the High Court that its Covid vaccine can, in very rare instances, cause Thrombotic Thrombocytopenic Syndrome (TTS). This rare side effect has been associated with the deaths of at least 81 people in the UK, as well as a number of serious injuries. As a result, the company has voluntarily withdrawn the Marketing authorization of its Covid vaccine from Europe and other global markets. [ad_1]

[cavenewstimes]

'Safety first', says Bharat Biotech amid AstraZeneca row

NEW DELHI: Bharat Biotech on Thursday assured Covaxin ‘s safety amid debate over Astrazeneca ‘s admission that its Covid-19 vaccine , sold as Covishield in India, could cause “rare’ side effects.The vaccine company posted a statement on X, mentioning that Covaxin was the sole Covid-19 vaccine in the government’s Covid-19 immunisation programme to have conducted efficacy trials in India. The…

[ednetconsultant]

Some Basic Requirements that you need to know before applying for a Canada Study Visa

Canada continues to attract lots of international students in 2024 as well. Lots of students want to go to Canada from India for further education. There are lots of things that any student needs to know before applying for a Canada study visa. But as a student, you can't gather that much information so it is advised to visit Study abroad consultants in Delhi for Canada. The consultants will guide you and help you at every step, not only this they will let you know all the requirements related to the Canada study visa. 

To get admission to Canada you must have excellent academic scores. The study permit will be issued at the time of the arrival in Canada. Know you want to know how Indian students can study in Canada and what are the important things any student needs to know. 

What do you understand by a Canada Study Permit?

This is a type of document that is issued by the Canadian immigration government authorities and serves as permission for international students to study in Canada. Any international student can't study in Canada without this permission. 

For to get your permit for Canada you need to carry some specific documents with you. while applying for a Canada visa there are lots of important things which need to be fulfilled. 

For Canada study visas students need to carry the letter of introduction with the other important documents as well. 

Some basic eligibility criteria for a study permit in Canada. 

You need to Qualify as a fully vaccinated Traveller. In Canada, there are some accepted vaccines such as AstraZeneca/COVISHIELD, Bharat Biotech Covaxin, etc.

you need to show or you should have specific documents to show that you have adequate funds to pay your tuition fees, living expenses, return transportation for yourself, etc.

you need to show proof of your clear background with no criminal record. The student should have a police verification certificate with them. 

you need to show your medical certificates as well that you don't have any major health problems. 

when you get your college acceptance letter only after that you can apply for a study permit in Canada. 

Apart from these, there are some valid documents which are required for the visa.

The first one is a valid passport. According to the Canadian government, your passport validity covers the intended stay In Canada. Suppose you are planning to travel to Canada for a year course in September 2022 then your passport should be valid until at least September 2024. 

Acceptance letter from college and university you are going to attend. 

All the proofs of funds.

Passport-size photographs.

Immigration Medical Examination Result

English Language Proficiency Exam score is very important. 

Statement of purpose and credit card. 

so if you are planning to study in Canada or Study in the USA consultants in Delhi, you need to consult Ednetconsultants for that. You will get proper guidance regarding your admission. 

[more-savi]

The Vaccine War 2023 Movie

The Vaccine War 2023 Movie Review by Moreshanaya

Type Documentary & Drama Film Language Hindi OTT Platform Theatre / Disney Hotstar Director Vivek Agnihotri Producer Pallavi Joshi Genre Thriller The Vaccine War is a 2023 Hindi-language medical docudrama film directed by Vivek Agnihotri and produced by Pallavi Joshi. It highlights the efforts of scientists in making Covaxin Production during the COVID-19 pandemic in India. This movie is based on the the book 'Going Viral' by Indian Council of Medical Research Professor Balram Bhargava . It stars Nana Patekar, Pallavi Joshi, Raima Sen, Anupam Kher, Girija Oak, Nivedita Bhattacharya, Saptami Gowda and Mohan Kapoor. Vaccine War was formally released on 28 September 2023 with mixed reviews from critics. The film received praise for its performances, direction and the challenges faced by scientists during the pandemic. The story of the vaccine war is the time for the scientific community to create safe and effective vaccines to combat COVID-19. The film focuses on the work of the National Institute of Virology and the Indian Council of Medical Research, discussing the challenges faced in producing vaccines. Nana Patekar, the center of the film, plays an important role in the story. It gives an inside look at scientists' efforts to tackle the pandemic and highlights the challenges faced in creating vaccines. Overall, this is an entertaining and inspiring film that offers a different perspective on one of the biggest public health issues today. The Vaccine War 2023 Movie Trailer https://youtu.be/Y-ULaz6I9oY Frequently Asked Questions: – Can this movie be seen with family? This is a Documentary + Drama Movie and as per movie there are no bad scenes, so that we can say that this film can be seen with family. How can we watch this movie? This movie is has released on Disney Hotstar on 23rd November 2023, so if you want to watch this movie you should take a subscription of Disney Hotstar. Also Read - M3GAN Movie Star-cast Release date Story Review Read the full article

[takataktop]

The Role of Women Highlighted in The Vaccine War Review by Vivek Agnihotri's Film

The Vaccine War Review showcases the dedication and commitment of Indian scientists during a tumultuous period. India was grappling with a massive surge in coronavirus cases, and chaos was rampant. The film also portrays how some individuals worked relentlessly to undermine India's own vaccine efforts while promoting foreign vaccines.

The Vaccine War Review: After depicting the pain of Kashmiri Pandit exodus in 'The Kashmir Files,' Vivek Agnihotri returns with 'The Vaccine War.' The film was released in cinemas on September 28th. Read more : OTT Game Changer: OTT Rights Sold for Ram Charan-Kiara's Film Before Theatrical Release, Deal Worth Crores The story of 'The Vaccine War' is primarily inspired by the book 'Going Viral - Making of Covaxin' by Dr. Balram Bhargava, the Director-General of the Indian Council of Medical Research (ICMR). Nana Patekar portrays his character in the film. The film underscores India's self-reliance in producing vaccines to combat the coronavirus. It also sheds light on the conspiracy by foreign forces that did not want India to succeed in vaccine production and attempted to discredit it. Some people questioned why we weren't using foreign vaccines. What's the Story of 'The Vaccine War'? The story begins in January 2020 when the first case of coronavirus emerged from Wuhan. The investigation into the origin of the virus commenced, leading to vaccine development processes at the National Institute of Virology (NIV) in Pune. Pallavi Joshi plays the role of Dr. Priya Abraham, the Director of NIV. She faces immense pressure and responsibility, initially doubting whether she can develop a vaccine in such a short time. Meanwhile, the situation in the country worsens, another lockdown is imposed, and people start dying. These events inspire Dr. Abraham, and she isolates the coronavirus and begins developing the vaccine. Screenplay and Performances 'The Vaccine War' can be considered India's first bio-medical film. Such films often involve scientific terminology, which might be challenging for viewers who are not well-versed in science. Many scientific aspects may go over the heads of the general audience. The film uses English dialogues extensively to make it more relatable to the audience. However, it may still pose some difficulties for the average viewer. The film attempts to depict a conspiracy to discredit our vaccine and shows how many people conspired to undermine our vaccine's effectiveness. However, this angle is not convincingly justified. Moreover, the portrayal of the media could have been handled better. Nana Patekar delivers a powerful performance, portraying a strict but vigilant officer in Dr. Balram Bhargava's role. Anupam Kher plays the role of the Cabinet Secretary. The government's role in vaccine production is briefly shown. Pallavi Joshi's performance is commendable. 'The Vaccine War' starts feeling somewhat like a documentary after a while. The abundance of office scenes with repetitive dialogues makes the film feel a bit long, lasting approximately two hours and forty minutes." Read more : Fukrey 3 Twitter Review: Did 'Fukrey 3' Live Up to the Hype? Let's Find Out How Pandit Ji and Choocha's Comedy Fared Read the full article

[harishbilgi-blog]

Coexisting with Covaxine

Coexisting with Covaxine : My quick take on Vivek Agnihotri’s “The Vaccine war” (Theatrical release) A tale of triumph, the saga of unwavering commitment, story of telling the world that India can do it, Mera Bharat, indeed, is truly mahān – a land where aspirations soar, barriers crumble, and where the indomitable human spirit conquers all odds. Take a bow Vivek agnihotri for bringing to light…

[decentralvaccine]

The Vaccine Wars Is India’s First Bio Cinematic Endeavor

Directed by Vivek Ranjan Agnihotri, 'The Vaccine War' is touted to be India's first bio-science cinematic endeavour. It talks about the scientists pivotal in developing the indigenous BBV152 vaccine, commonly known as Covaxin.

[5gdiginews]

BHU study on side effects of Covaxin misleading and erroneously acknowledges ICMR : Dr Rajiv Bahl - ET HealthWorld

New Delhi: The Indian Council of Medical Research (ICMR) cannot be associated with poorly designed studyTopic “Long Term Security Analysis Regarding the BBVl52 coronavirus vaccine in adolescents and adults: findings from a one-year prospective study in North India”, written by Kaur et al. in the Journal of Drug Safety Dr. Rajiv Bahl Director General, ICMR. In his letter, Dr. Bahl has asked the…

[medhahospital]

#Covid vaccination drive resumes in Ghaziabad after arrival of 30,700 doses Data from Ghaziabad health department shows that only 817,939 of 2,487,074 beneficiaries – or 32.88% – have received their precautionary dose Nearly 23 days after the entire stock of Covid-19 vaccine in Ghaziabad district ran dry, the health department has received about 30,700 doses of Covishield vaccine on Tuesday night. With the arrival of the fresh stock, government vaccination centres once again started functioning on Wednesday. According to officials, the district’s stock of Covid vaccine got exhausted on December 26, and they sent a communication to the state health department requesting Covishield, Covaxin and Corbevax. “We have received about 30,700 doses of Covishield and have started the vaccination process on Wednesday. Different community health centres, primary health centres and two district hospitals have started the vaccination process. Citizens who require Covishield as a first dose, second dose or precautionary dose can get the vaccine at our centres now,” said Dr GP Mathuria, nodal officer for Covid vaccination. The health department also issued a list of 57 government vaccination centres that include urban primary health centres, community health centres in Muradnagar, Loni, Dasna and Modinagar besides the two district hospitals of MMG District Hospital and Sanjay Nagar Combined District Hospital. According to official data, Ghaziabad district had a target of vaccinating 2,844,305 beneficiaries since the Covid-19 vaccination programme started on January 16, 2021. The district surpassed this target by vaccinating 3,008,932 people with both doses (first and second dose) till January 6, the data shows. However, the slow rate of administering precautionary dose and second dose to senior citizens in the 60+ years age group has raised concerns amid reports of a new Covid-19 strain spreading in China and other countries. Data from Ghaziabad health department shows that only 817,939 of 2,487,074 beneficiaries – or 32.88% – have received their precautionary dose. Of a target of administering two doses to 361,791 beneficiaries in the 60+ age group, only 298,653 (at Ghaziabad, India) https://www.instagram.com/p/Cnn-0yIhN_V/?igshid=NGJjMDIxMWI=

[znewstech]

Indian govt, Bharat Biotech rubbish reports of Covaxin development being rushed under political pressure | India News - Times of India

Indian govt, Bharat Biotech rubbish reports of Covaxin development being rushed under political pressure | India News – Times of India

HYDERABAD: The Indian government and Bharat Biotech on Thursday trashed reports of the development of indigenous Covid-19 vaccine Covaxin being rushed under political pressure as “incorrect, misleading and fallacious”. “Recent media reports around the approvals for Covaxin are incorrect and erroneous. These few individuals and organizations were mostly involved in fake news and false information…

[dailynews9]

Corbevax approved as a booster dose for adults

Corbevax approved as a booster dose for adults

Hyderabad / Delhi: In what is the first heterologous booster shot to be approved for use in India, Biological E’s Covid – 19 vaccine Corbevax has received the government’s nod for use as a precaution. It will be available for those aged 18 and above after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines, the health…

[joinnoukri]

Corbevax approved as booster dose for adults vaccinated with Covaxin, Covishield | Latest News India

Corbevax approved as booster dose for adults vaccinated with Covaxin, Covishield | Latest News India

केंद्र द्वारा नवीनतम कदम महत्वपूर्ण है क्योंकि यह पहली बार है कि देश में एक बूस्टर खुराक जो कि कोविड -19 के खिलाफ प्राथमिक टीकाकरण के लि�� इस्तेमाल की जाने वाली खुराक से अलग है, को अनुमति दी गई है। केंद्रीय स्वास्थ्य सचिव राजेश भूषण ने कहा कि केंद्र ने 18 साल से ऊपर की आबादी के लिए कोवैक्सिन या कोविशील्ड टीकों की दूसरी खुराक के प्रशासन की तारीख से छह महीने पूरे होने के बाद एहतियात के तौर पर…

[hindimaster]

Biological Corbevax Booster Shot For Covaxin And Covishield Beneficiaries Above 18 Years Of Age Approved By Government Of India | Corbevax Vaccine: कोवैक्सिन और कोविशील्ड लेने वाले लोग अब लगवा सकते हैं कॉर्बेवैक्स बूस्टर डोज

Biological Corbevax Booster Shot For Covaxin And Covishield Beneficiaries Above 18 Years Of Age Approved By Government Of India | Corbevax Vaccine: कोवैक्सिन और कोविशील्ड लेने वाले लोग अब लगवा सकते हैं कॉर्बेवैक्स बूस्टर डोज

Corbevax Vaccine: भारत सरकार के आधिकारिक सूत्रों ने जानकारी दी है कि 18 साल से ज्यादा के जो लोग कोवैक्सिन और कोविशील्ड लगवा चुके हैं, अब उनके लिए जैविक ‘ई कॉर्बेवैक्स बूस्टर शॉट’ उपलब्ध है. भारत सरकार ने ई कॉर्बेवैक्स बूस्टर शॉट को मान्यता दे दी है. ऐसे में जो लोग कोवैक्सिन और कोविशील्ड लगवा चुके हैं वो कॉर्बेवैक्स बूस्टर डोज लगवा सकते हैं. 24 घंटे में कोरोना संक्रमितों के 16,047 नए मामले वहीं…